Stocks to Buy

Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.

3 Fallen Tech Stocks to Scoop From the Wreckage

These 3 tech stocks to buy look compelling amid the recent tech stock sell-off in early September.

7 Debt-Free Stocks to Buy For Peace of Mind In Volatile Markets

There are a handful of companies with no debt in the stock market, but not all of them are worth a close look. Here are seven that are.

FDA Clearance Means It’s Go Time for Sorrento Therapeutics

It's a great time to be long SRNE stock as the company's ambitious Covid-19 treatment clinical trials take a giant step forward for Sorrento.

7 Sin Stocks To Buy That Will Outperform the S&P 500

Each of these seven sin stocks has something unique to offer to long-term portfolio, plus juicy dividends and solid fundamentals.

3 Fitness Stocks Whose Hard Work Can Reward You

The work(out)-from-home era has been a major boon for companies that cater to this trend. Here are three fitness stocks to buy right now.

Tesla Stock Dips After Battery Day Announcements

At Tesla’s highly anticipated Battery Day, Elon Musk outlined the company’s goals for a low-cost battery and a $25,000 electric vehicle. But investors remain underwhelmed by the CEO's grandiose plans.

Why Workhorse Group Stock Still Has Plenty of Horsepower

With patience, I strongly believe WKHS stock could double from here. The shares have multiple, strong catalysts.

Speculate on Inovio and Covid-19 Vaccine Developers

After bottoming at $10 earlier this month, investor interest soared in the last week for INO stock and the company's DNA medicine.

The 7 Best Stocks to Buy for the Fourth Quarter

This has been a wild year for most investors, but there are some stocks to buy that will help you end it on a high note more than others.

3 Big Reasons to Buy the September Dip in Facebook Stock

Near-term weakness is nothing more than a long-term buying opportunity in FB stock, which could rally 25% in 12 months.

Why Centene Is the Most Important Healthcare Stock

CNC stock holders found a company like Tesla in that it has a better technology than its rivals, in this case in managed healthcare.

4 New Stocks That Can Be Long-Term Value Creators

Here are new stocks to buy among IPOs and SPACs that have the potential to be creators of long-term value.

Why Investors Should Take a Serious, Bullish Look on Sorrento

Bears are waging a heavy and crowded bet against SRNE stock, but more good news could send the stock higher.

Peloton Stock is a Strong Buy Into Support

Peloton stock just tagged a new record at $100 after its recent earnings bonanza. Here's the next trading setup to watch for before buying.

As the Company Helps Build China’s Smart Cities, Stay With Ericsson Stock

Ericsson’s Radio Dot System is transforming the Chinese city of Shenyang. It’s another reason Ericsson stock is a smart 5G play.

9 Growth Stocks That Could Double During the New Normal

While the coronavirus pandemic is thankfully fading in magnitude, the changes it has caused may stay with us for a long time. Here are nine growth stocks that can likely advantage the new normal.

As Remote Work Becomes the Norm, Slack Remains Solid

Despite the recent pullback in Slack stock, the shift to remote work is here to stay even after the coronavirus pandemic comes to an end.

3 Gold Stocks for Any Market Conditions (but Especially Now)

Gold stocks are likely to deliver robust returns as expansionary monetary policies continue. A weaker dollar is likely to take gold higher in the coming years.

Patient Investors Will Stick With Very Cheap Bristol-Myers Squibb Stock

Stick with Bristol-Myers Squibb stock which is incredibly cheap. BMY stock is worth at least 46% more than today, based on its historical yield, P/E ratios, and peer comparisons.